TRANSFORMING PATIENT CARE
We are committed to offering integrated technologies that are less invasive and more cost-effective for the millions suffering from chronic rhinosinusitis.
![propel-icons](https://www.intersectent.comwp-content/uploads/propel-icons.png)
![PROPEL_Family_Logo](https://www.intersectent.com/wp-content/uploads/PROPEL_Family_Logo.png)
Instructions For Use
PROPEL: US | EU | Patient Implant Information Leaflet (EU)
PROPEL Mini: US | EU | Patient Implant Information Leaflet (EU)
PROPEL Mini with SDS: US
PROPEL Contour: US | EU
![PROPEL_Family_Logo](https://www.intersectent.com/wp-content/uploads/PROPEL_Family_Logo.png)
![sinuva-icon](https://www.intersectent.comwp-content/uploads/sinuva-icon.png)
The above-identified implants, delivery systems, and/or the use of the above-identified implants/delivery systems in a method may be covered by one or more U.S. and/or foreign patents, found at intersectent.com/patents